Department Name |
Source |
Finacial Year |
Amount Sanctioned |
Purpose |
Not Specified |
Any Other |
2015-2016 |
Not Specified |
Project Sanction no. BT/MB/DBT-NBE/5/2012 entitled "Implementation of 3 years DNB Program in Medical Genetics by DBT in collaboration with NBE. There was unspent balance of Rs. 30,66,092 from previous financial year (2014-15) and therefore no fresh grant was received. |
Department of Biotechnology |
Central |
2016-2017 |
3633683 |
Project Sanction no. BT/MB/DBT-NBE/5/2012 entitled "Implementation of 3 years DNB Program in Medical Genetics by DBT in collaboration with NBE. |
Department of Biotechnology |
Central |
2017-2018 |
6055500 |
Project Sanction no. BT/MB/DBT-NBE/5/2012 entitled "Implementation of 3 years DNB Program in Medical Genetics by DBT in collaboration with NBE. |
Not Specified |
Any Other |
2018-2019 |
Not Specified |
Project Sanction no. BT/MB/DBT-NBE/5/2012 entitled "Implementation of 3 years DNB Program in Medical Genetics by DBT in collaboration with NBE. |
Indian Council of Medical Research |
Central |
2017-2018 |
1789034 |
Regional Centre for Antimicrobial Resistance Surveillance Network, Sir Ganga Ram Hospital vide Sanction Letter No. AMR/RC/65/2014-ECD-II; Period 01.03.2017 to 28.02.2018 |
Indian Council of Medical Research |
Central |
2020-2021 |
2032065 |
Phase I-II Clinical Trial on Safety, Immunogenicity and probing efficacy of the Revived Recombinant Vaccine against Human Chorionic Gonadotropin (hCG) vide Sanction Letter No. 5/10/17/2009-RHN; Period March 2020-Feb 2021 |
Indian Council of Medical Research |
Central |
2019-2020 |
1213676 |
Sir Ganga Ram Hospital: Initiating Antimicrobial Stewardship activities in hospitals in India Phase II vide Sanction Letter No. AMR/129/2018-ECD-II (e-File No. 86962); Period Oct 2019 to Oct 2020 |
Defence Research and Development Organisation |
Central |
2020-2021 |
3997224 |
Exploring Novel Biomarkers in Indian Pulmonary Arterial Hypertension Patients through Transcriptomics Approach vide Sanction Letter No. O/o LSRB/81/48222/LSRB-369/PEE |
Indian Council of Medical Research |
Central |
2020-2021 |
2292598 |
Identification of plasma- derived exosomal protein biomarkers for early prediction of dengue severity in Indian children vide Sanction Letter No. VIR/24/2020/ECD-I; Period 15.01.2021 o 14.01.2022 |
Department of Biotechnology |
Central |
2019-2020 |
4590400 |
Does variable CYP24 gene promoter activity in kidney explain the variable response of serum 25- hydroxyvitamin D levels following vitamin D supplementation vide Sanction Letter No. BT/PR17922/PFN/20/1221/2016 |
Department of Biotechnology |
Central |
2020-2021 |
Not Specified |
Does variable CYP24 gene promoter activity in kidney explain the variable response of serum 25- hydroxyvitamin D levels following vitamin D supplementation vide Sanction Letter No. BT/PR17922/PFN/20/1221/2016 (for F.Y. Ending 27.01.2021). Amount remaining unspent in previous F.Y. is Rs 1847460/- |
Indian Council of Medical Research |
Central |
2017-2018 |
3913980 |
Phase I-II clinical trial on safety, immunogenicity and probing efficacy of the recombinant vaccine against human chronic Gonadotropin (hCG) vide Sanction Letter No. 5/7/17/2009-RHN |
Indian Council of Medical Research |
Central |
2018-2019 |
Not Specified |
Phase I-II clinical trial on safety, immunogenicity and probing efficacy of the recombinant vaccine against human chronic Gonadotropin (hCG) vide Sanction Letter No. 5/7/17/2009-RHN; Period 01.03.2018 to 28.02.2019. NIL grant received on account of unspent balance from FY 2017-18. |
Indian Council of Medical Research |
Central |
2019-2020 |
4983720 |
Phase I-II clinical trial on safety, immunogenicity and probing efficacy of the recombinant vaccine against human chronic Gonadotropin (hCG) vide Sanction Letter No. 5/7/17/2009-RHN; Period 01.03.2019 to 29.02.2020. (Rs 2967300/- unspent balance of FY 2018-19 carried forward) |
Indian Council of Medical Research |
Central |
2020-2021 |
1404060 |
Phase I-II clinical trial on safety, immunogenicity and probing efficacy of the recombinant vaccine against human chronic Gonadotropin (hCG) vide Sanction Letter No. 5/7/17/2009-RHN; Period 01.03.2020 to 28.02.2021. Unspent balance of previous FY carried forward. |
Indian Council of Medical Research |
Central |
2019-2020 |
1403568 |
National Registry for Rare and other Inherited Disorders (NRROID) vide Sanction Letter No RBMCH/CAR/02/2019-20; Period 01.11.2019 to 31.03.2021 |
Indian Council of Medical Research |
Central |
2017-2018 |
1298640 |
Screening and identification of cellular targets of small molecules in ameliorating amyloid disorders using yeast model vide Sanction Letter No. BMS/ADHOC/BIOCHEM/2015-0430/NOV/2015/09/DL/PVT; Period 01.12.2017 to 30.11.2018 |
Indian Council of Medical Research |
Central |
2018-2019 |
1269344 |
Screening and identification of cellular targets of small molecules in ameliorating amyloid disorders using yeast model vide Sanction Letter No. BMS/ADHOC/BIOCHEM/2015-0430/NOV/2015/09/DL/PVT; Period 01.12.2018 to 30.11.2019 |
Indian Council of Medical Research |
Central |
2018-2019 |
829500 |
Evaluation of a simulation based scoring system in inhibition of identified molecular targets; dihydrodipicolinate synthase (DapA) of Mycobacterium tuberculosis and Superoxide dismutase (SOD1) associated with Amyotrophic Lateral Sclerosis in humans vide Sanction Letter No. BIC/5/(09)/Indo-Russian/2016; Period 15.01.2018 to 14.01.2019 |
Indian Council of Medical Research |
Central |
2019-2020 |
900750 |
Evaluation of a simulation based scoring system in inhibition of identified molecular targets; dihydrodipicolinate synthase (DapA) of Mycobacterium tuberculosis and Superoxide dismutase (SOD1) associated with Amyotrophic Lateral Sclerosis in humans vide Sanction Letter No. BIC/5/(09)/Indo-Russian/2016; Period 15.01.2019 to 14.01.2020 |
Indian Council of Medical Research |
Central |
2020-2021 |
825594 |
Evaluation of a simulation based scoring system in inhibition of identified molecular targets; dihydrodipicolinate synthase (DapA) of Mycobacterium tuberculosis and Superoxide dismutase (SOD1) associated with Amyotrophic Lateral Sclerosis in humans vide Sanction Letter No. BIC/5/(09)/Indo-Russian/2016; Period 15.01.2020 to 14.01.2021 |
Indian Council of Medical Research |
Central |
2018-2019 |
768922 |
Regional Centre for Antimicrobial Resistance Surveillance Network, Sir Ganga Ram Hospital vide Sanction Letter No. AMR/RC/65/2014-ECD-II; Period 01.03.2018 to 08.03.2019. Unspent Balance of Rs 406421/- carried forward from previous year |
Indian Council of Medical Research |
Central |
2019-2020 |
820810 |
Regional Centre for Antimicrobial Resistance Surveillance Network, Sir Ganga Ram Hospital vide Sanction Letter No. AMR/RC/65/2014-ECD-II; Period 01.03.2019 to 18.03.2020. Unspent Balance of Rs 56271/- carried forward from previous year |
Indian Council of Medical Research |
Central |
2020-2021 |
844698 |
Regional Centre for Antimicrobial Resistance Surveillance Network, Sir Ganga Ram Hospital vide Sanction Letter No. AMR/RC/65/2014-ECD-II; Period 01.03.2020 to 28.02.2021. Unspent Balance of Rs 79534/- carried forward from previous year |
Feedback / Rewiews
Leave your comment (spam and offensive messages will be removed)